GLP-1 (7-36) amide (Human, Rat, Mouse, Porcine, Bovine, Canine, Ovine) - EIA Kit


Catalog #
EK-028-11 96 wells $537

  • Protocol:
  • View/Download (PDF) - for reference only
  • Sample Preparation:
  • Suggested Procedure
  • Measured Sample Levels: polaroid
    Measured values represent approximate 'normal' levels in sample, but do not signify the only possible sample levels. Various factors (e.g. sample storage, assay procedure) can affect results.
  • 16 ± 1 pmol/L
  • Sample Extraction:
  • Recommended
  • Sensitivity: polaroid
    Data may differ slightly based on lot.
  • 0.11 ng/ml
  • Linear Range: polaroid
    Data may differ slightly based on lot.
  • 0.11 - 1.09 ng/ml
  • Cross Reactivity:
  • Peptide %
    GLP-1 (7-36) (Human, Rat, Mouse) 100
    GLP-1 (9-36) Amide 100
    GLP-1 (1-36) Amide (Human) 100
    GLP-1 (7-37) (Human, Rat, Mouse) 0.4
    GLP-2 (Human) 0
    Glucagon (Human, Rat, Mouse, Porcine, Bovine) 0
    CGRP 0
    GIP 0
    VIP 0
    Insulin 0
    Exendin-4 0

  • Intra-assay variation:
  • <10%
  • Inter-assay variation:
  • <15%
Standard Curve:

Expression of genes related to energy metabolism (osteocalcin, FOXO1, insulin receptor, and SOST) in bone cells of Goto-Kakizaki rats and response to bariatric surgery.
Pérez-castrillón JL, Riancho JA, De luis D, Gonzalez-sagrado M, Domingo-andres M, Dueñas-laita A. Surg Obes Relat Dis. 2014;10(2):299-303.

Long-term inhibition of intestinal lipase by orlistat improves release of gut hormones increasing satiety in obese women.
Olszanecka-glinianowicz M, D?browski P, Koce?ak P, et al. Pharmacol Rep. 2013;65(3):666-71.

Effect of two types of bariatric surgery (gastrojejunal bypass and sleeve gastroplasty) on gene expression of bone remodeling markers in Goto-Kakizaki rats.
Pérez-castrillón JL, Riancho JA, De luis D, et al. Obes Surg. 2014;24(1):37-41.

Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents.
Mencarelli A, Renga B, D'amore C, et al. Diabetes. 2013;62(10):3384-93.

Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease.
Drafts BC, Twomley KM, D'agostino R, et al. JACC Cardiovasc Imaging. 2013;6(8):877-85.

GLP-1 and peptide YY secretory response after fat load is impaired by insulin resistance, impaired fasting glucose and type 2 diabetes in morbidly obese subjects.
Fernández-garcía JC, Murri M, Coin-aragüez L, Alcaide J, El bekay R, Tinahones FJ. Clin Endocrinol (Oxf). 2014;80(5):671-6.

Basal glucagonlike peptide 1 levels and metabolic syndrome in obese patients.
De luis DA, Aller R, Conde R, et al. J Investig Med. 2012;60(6):874-7.

The deleterious effect of bariatric surgery on cortical and trabecular bone density in the femurs of non-obese, type 2 diabetic Goto-Kakizaki rats.
Pérez-castrillón JL, Riancho JA, De luis D, et al. Obes Surg. 2012;22(11):1755-60.

Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease.
Yamaoka-tojo M, Tojo T, Takahira N, et al. Cardiovasc Diabetol. 2010;9:17.

Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function.
Granata R, Settanni F, Gallo D, et al. Diabetes. 2008;57(4):967-79.

Enterohormonal changes after digestive adaptation: five-year results of a surgical proposal to treat obesity and associated diseases.
Santoro S, Milleo FQ, Malzoni CE, et al. Obes Surg. 2008;18(1):17-26.

The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats.
Pacheco D, De luis DA, Romero A, et al. Am J Surg. 2007;194(2):221-4.

Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model.
Suzuki S, Ramos EJ, Goncalves CG, Chen C, Meguid MM. Surgery. 2005;138(2):283-90.